Medicare “reconsiders” hepatitis B codes

Why This Topic Matters

The article addresses Medicare instructions that can affect whether claims are accepted, denied, or require system updates. It helps readers understand the scope of a CMS memo, identify which coding and diagnosis code sets are implicated, and recognize that Medicare coverage policy changes may require payer and software review.

Article Sections

1. Medicare reverses hepatitis B injection coding change

   Covers a CMS program memo that revises a previously announced Medicare coding update for hepatitis B injection reporting. The section discusses the affected Medicare coding framework and the operational impact on claims systems.

2. NMES coverage guidance for Medicare

   Summarizes Medicare coverage guidance for neuromuscular electrical stimulation services and the related program memo. The section outlines the general service context, applicable coverage conditions, and claim review considerations.